Advertisement

Topics

Minerva Pharmaceuticals Company Profile

02:47 EST 25th November 2017 | BioPortfolio

Minerva Pharmaceuticals, Inc. is a biopharmaceutical product development company dedicated to detecting and eliminating cancer before clinical symptoms occur.

Location

Technology Development Center1414 Key Highway
Baltimore
MD
21230
United States of America

Contact

Phone: 410.752.2221
Fax: 410.752.2456
Email: info@minervapharmaceuticals.com


News Articles [477 Associated News Articles listed on BioPortfolio]

Minerva Neurosciences, Inc.: Minerva Neurosciences Names Dr. Justine Lalonde as Senior Vice President, Product Strategy

WALTHAM, Mass., 2017-10-31 13:00 CET (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat centr...

Minerva Neurosciences, Inc.: Minerva Neurosciences, Inc. to Offer Common Shares

WALTHAM, Mass., 2017-06-27 22:10 CEST (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company, today announced its intention to offer and sell 5,00...

Minerva Neurosciences, Inc.: Minerva Neurosciences Reports Third Quarter 2017 Financial Results and Business Updates

WALTHAM, Mass., 2017-11-06 13:30 CET (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat centr...

Minerva Neurosciences, Inc.: Minerva Neurosciences Announces Pricing of Public Offering of Common Stock

WALTHAM, Mass., 2017-06-29 00:45 CEST (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company, today announced the pricing of an underwritten publi...

Minerva Neurosciences, Inc.: Minerva Neurosciences Names Dr. Jay Saoud as Senior Vice President, Head of Research and Development

WALTHAM, Mass., 2017-09-11 14:30 CEST (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat cent...

Minerva Neurosciences, Inc.: Minerva Neurosciences to Present at Jefferies 2017 London Healthcare Conference on November 15, 2017

WALTHAM, Mass., 2017-11-08 15:00 CET (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat centr...

Minerva Neurosciences, Inc.: Minerva Neurosciences to Report Third Quarter 2017 Financial Results and Business Updates on November 6, 2017

Management to host conference callWALTHAM, Mass., 2017-10-30 13:30 CET (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the devel...

Minerva Neurosciences, Inc.: Minerva Neurosciences Announces European Commission Approval of Amendment of MIN-202 Agreement With Janssen

Proceeds from amended agreement, combined with finances raised from recent public stock offering and current financial resources, significantly extend Minerva cash runway Combined proceeds are expe...

Drugs and Medications [270 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]

EYEWASH STATION ADDITIVE CONCENTRATE

PubMed Articles [153 Associated PubMed Articles listed on BioPortfolio]

EFFICACY AND SAFETY OF RANIBIZUMAB FOR THE TREATMENT OF CHOROIDAL NEOVASCULARIZATION DUE TO UNCOMMON CAUSE: Twelve-Month Results of the MINERVA Study.

To evaluate the efficacy and safety of ranibizumab 0.5 mg in adult patients with choroidal neovascularization because of an uncommon cause enrolled in the 12-month MINERVA study.

Announcing the 2017 Pharmaceuticals Travel Award for Young Post-Doctoral Researchers.

Last year, for the first time in its history, our Journal was able to offer a travel grant of 800 CHF to a young researcher in the field of medicinal chemistry.

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Chiral pharmaceuticals: A review on their environmental occurrence and fate processes.

More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the same pharmaceutical have identical physicochemical properties, but may exhibit differences in pharmacokinetics,...

The terminally ill: can we prevent suffering?

Clinical Trials [208 Associated Clinical Trials listed on BioPortfolio]

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

MINERVA: MINimizE Right Ventricular Pacing to Prevent Atrial Fibrillation and Heart Failure

The aim of this study is to test the impact of the managed ventricular pacing (MVP) mode and atrial preventive and antitachycardia pacing therapies on the reduction of a composite clinical...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects Under Fasting Condition

- Objective: - To compare the rate and extent of absorption of Citalopram Hydrobromide Tablets 40 mg: Test Product: Citalopram Hydrobromide Tablets 40 mg manufactured b...

Companies [1292 Associated Companies listed on BioPortfolio]

Minerva Pharmaceuticals

Minerva Pharmaceuticals, Inc. is a biopharmaceutical product development company dedicated to detecting and eliminating cancer before clinical symptoms occur.

Minerva Biotechnologies

Minerva Biotechnologies is a pioneer in the field of stem cells and cancer stem cells. Minerva was first to discover that cancer cells hijack an otherwise normal stem cell growth ...

Minerva Biolabs GmbH

Minerva Biolabs is committed to providing highest quality in products and services.1999 The company was established in August 1999 as a spin-off from the Robert-Koch Institute (RKI) in Berlin. Minerva...

Minerva Holdings Inc.

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

More Information about "Minerva Pharmaceuticals" on BioPortfolio

We have published hundreds of Minerva Pharmaceuticals news stories on BioPortfolio along with dozens of Minerva Pharmaceuticals Clinical Trials and PubMed Articles about Minerva Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Minerva Pharmaceuticals Companies in our database. You can also find out about relevant Minerva Pharmaceuticals Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record